Simpulse PLUS System

Angled insertion forcep used for the Hydroview lens. Manufactured in titanium.

Biconvex jaw design. 40 degree angled shafts. Tip to angle length: 7.5 mm. Locking handle. Manufacturing in titanium.

Titanium. Designed to easily fold the hydroview lens. Will also fold many styles of soft intraocular lenses. Unique cross-action design facilitates folding of the lens.

Curved shafts with serrated 1.5 mm upper and 2 mm lower jaws. Serrated cross action handle with slide lock and polished finish. Most popular size or model.

(Date:9/5/2008)...G, Pa., Sept. 5 /PRNewswire-USNewswire/ -- Childre...r access to comprehensive,services to protect thei...n,in grants that were announced today by the Depar...vices for children and families, the department,be...ren,s Services Planning,initiative, ICSP, in 2004....

(Date:9/5/2008)..., Md., Sept. 5 /PRNewswire-USNewswire/ -- The Heal...day announced $39 million in grants to,increase an...centers., "These grants continue President Bush,s...whose services now reach more economically,vulnera...r before," HRSA,Administrator Elizabeth M. Duke sa...

(Date:9/5/2008)...ontrolled, but you need to know what triggers them...thDay News) -- If you are one of the 36 million Am...is nowhere in the United States that is free from ... shows. , Allergies don,t only happen in the sp...ell. In the fall, the most challenging cities to l...

(Date:9/5/2008)...N, Sept. 5 /PRNewswire-USNewswire/ -- Speaker Nanc...upport of the aims of the "Stand,Up to Cancer" tel...re is not a person in our country who has not seen...s 565,000 Americans annually, and each,year there ... must work,together to make eradicating the scourg...

...ed later this month at the World Health Organizati...dvertisements targetting// children. The draft WH...ussed on vulnerable groups such as children and ad...be exploited by commercial activities." It calls f...

... cancer retinoblastoma has been developed by scien... demonstrated// in a mouse model to cause a remark...ausing the side effects common with standard chemo...o be suitable for certain forms of breast, lung, p...

... an expectant mother does not play an important ro...a low-weight baby.// Since one in ten babies are b...s them prone to a host of health problems, that in...tists thought it imperative to examine if treating...

...s year, an estimated 151 million doses, its distri... Family Practice, for instance ordered 750 doses b...ay. On the other hand at York Hospital, 9,000-plus...John Phylis, director of pharmacy for York hospita...

(Date:9/3/2008)... September is National Vascular Disease Awareness ... -- Diffusion Pharmaceuticals,LLC, a clinical-stag...gs,for the treatment of unmet medical needs, annou... a Phase I/II clinical trial of its lead drug,cand...esignated NCT00725881,on the clinicaltrials.gov We...

(Date:9/3/2008)...RSBURG, Md., Sept. 3 /- Panacea Pharm....S. Patent Number 7,413,737 covering,antibodies ag...e (HAAH), a,proprietary human cancer biomarker and...ed in collaboration with the Massachusetts Institu...worldwide rights to this patent,for development of...

(Date:9/3/2008)... Company to Discuss Phase 3 Plans with FDA, ...erapeutics, Inc.,announced today that it successf...lopment of the company,s new, innovative low-dose,...ny refers to by its internal product,code AG-200-1...ully met its,primary endpoint of ovulation suppres...

(Date:9/3/2008)...nical Trial Reconfirms Strong Evidence Pycnogenol(...ing Effect on Joints Following Cessation ... Sept. 3 /- According to the Center f... common type of arthritis,is on the rise. A new s...py,Research, reveals Pycnogenol(R), bark extract f...

...ne 04, 2007 /PRNewswire-FirstCall/ -- Kosan,Biosci... a Phase 2,monotherapy trial showing that tanespim...ity in patients with metastatic melanoma,includin... failed,prior chemotherapy (within 6 weeks of init...gression-free survival for more than,six months an...

...ne 04, 2007 /PRNewswire-FirstCall/ -- Kosan,Biosci...linical,trial showing that KOS-1584/R1645, an epot...ed promising antitumor,activity and tolerability i...d activity in 32% of patients (13 of 41,evaluable)...l lung,ovarian, breast, prostate, head and neck a...